Free Trial

Zacks Research Cuts Earnings Estimates for Henry Schein

Henry Schein logo with Medical background

Key Points

  • Zacks Research has lowered its Q1 2027 earnings estimate for Henry Schein to $1.38 per share, down from a previous estimate of $1.39.
  • Henry Schein's stock currently has an average target price of $76.67 and a consensus rating of "Hold" among analysts, with five analysts rating it as a Buy.
  • The company reported $1.10 earnings per share in its last earnings release, which was below the analysts' consensus estimate of $1.19.
  • MarketBeat previews top five stocks to own in November.

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Investment analysts at Zacks Research reduced their Q1 2027 earnings per share (EPS) estimates for shares of Henry Schein in a report released on Tuesday, October 14th. Zacks Research analyst Team now forecasts that the company will earn $1.38 per share for the quarter, down from their previous forecast of $1.39. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share.

A number of other equities analysts also recently issued reports on the company. Barrington Research reissued an "outperform" rating and set a $78.00 target price on shares of Henry Schein in a research note on Tuesday, September 23rd. Robert W. Baird reaffirmed a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Evercore ISI raised Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a research note on Tuesday, August 26th. Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Henry Schein in a research note on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $76.67.

Get Our Latest Analysis on HSIC

Henry Schein Stock Performance

Shares of HSIC stock opened at $63.25 on Thursday. The company has a market cap of $7.67 billion, a price-to-earnings ratio of 20.40, a price-to-earnings-growth ratio of 2.09 and a beta of 0.81. The stock has a 50 day simple moving average of $67.25 and a 200-day simple moving average of $68.68. Henry Schein has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business's quarterly revenue was up 3.3% on a year-over-year basis. During the same period last year, the company posted $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Vanguard Personalized Indexing Management LLC increased its position in shares of Henry Schein by 3.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company's stock worth $341,000 after acquiring an additional 157 shares during the last quarter. Equitable Trust Co. grew its stake in Henry Schein by 3.1% in the second quarter. Equitable Trust Co. now owns 5,317 shares of the company's stock worth $388,000 after purchasing an additional 158 shares in the last quarter. CW Advisors LLC grew its stake in Henry Schein by 2.8% in the second quarter. CW Advisors LLC now owns 5,913 shares of the company's stock worth $432,000 after purchasing an additional 163 shares in the last quarter. TD Asset Management Inc grew its stake in Henry Schein by 0.8% in the second quarter. TD Asset Management Inc now owns 22,016 shares of the company's stock worth $1,608,000 after purchasing an additional 164 shares in the last quarter. Finally, Radnor Capital Management LLC grew its stake in Henry Schein by 1.6% in the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company's stock worth $834,000 after purchasing an additional 180 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.